EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Beta‐Thalassemia in Spain: Results From the National Thalassemia Registry and Molecular Analysis of Patients With Transfusion‐Dependent Thalassemia

Ana Villegas, Paloma Ropero iD, Fernando Ataulfo González, Marta Morado, María Menor iD, Silvia de la Iglesia, Montserrat López-Rubio, Eduardo José Salido, Mariola Abío, María Leonor Senent, Valle Recasens, José Manuel Vagace und 30 weitere

Journal of Clinical Laboratory Analysis · 2026-07 · 40 (14)

DOI: 10.1002/jcla.70272 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 02.06.2026. Verfasst von Ana Villegas und 41 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: beta-Thalassemia, Blood Transfusion. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agios Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Beta‐thalassemia is a genetically heterogeneous hemoglobinopathy with marked clinical variability. In Spain, comprehensive nationwide data on transfusion‐dependent beta‐thalassemia (TDT) remain limited, particularly regarding molecular characterization.

Methods

This observational study analyzed data from the National Thalassemia Registry of the Spanish Society of Hematology and Hemotherapy (SEHH). Between November 2022 and February 2025, 147 patients with beta‐thalassemia from 42 hospitals were registered; this report focuses on 78 patients with TDT. Clinical, transfusion, and biochemical data were collected, and molecular analysis of the HBB and HBA genes was performed using Sanger sequencing, next‐generation sequencing, and complementary techniques. Genotypes were classified according to the degree of beta‐globin synthesis reduction.

Results

The mean age of TDT patients was 34.3 years, and 73.1% were of Spanish origin. Patients received a mean of 31.4 packed red blood cell units per year. Splenectomy had been performed in 35.9% of cases. Most patients showed adequate iron overload control, with median serum ferritin levels below 1000 ng/mL. Twenty‐four different HBB mutations were identified; the most frequent were CD39 (C > T), IVS‐1‐nt1 (G > A), IVS‐1‐nt110 (G > A), IVS‐1‐nt6 (T > C), and IVS‐1‐nt1 (G > T), accounting for 75% of alleles. Genotype distribution was 55.2% β 0 /β 0 , 30.3% β 0 /β + , and 14.4% β + /β + . Patients with β + /β + genotypes had significantly lower ferritin levels.

Conclusions

This nationwide registry highlights the genetic and clinical heterogeneity of TDT in Spain and underscores the value of molecular characterization for patient management, genetic counseling, and future therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaBlood TransfusionHumansFemaleSpainRegistriesAdultMalebeta-GlobinsAdolescentYoung AdultMutationGenotypeMiddle AgedChild

Stichwörter der Autor:innen

HBB mutationsbeta‐thalassemiamolecular geneticsnational registrytransfusion‐dependent thalassemia

Substanzen

beta-Globins

Autor:innen und Institutionen

  • Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
  • Instituto de Investigación Sanitaria San Carlos (IdISSC) Hospital Clínico San Carlos, Madrid, Spain.
  • Sociedad Española de Hematología y Hemoterapia, Madrid, Spain.
  • Hospital Universitario Príncipe de Asturias, Madrid, Spain.
  • Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain.
  • Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.

ORCID-Profile: Paloma Ropero, María Menor, Jesús María Hernández-Rivas, María Angustias Molina

Förderung

  • Agios Pharmaceuticals

Zitieren

APA

Villegas, A., Ropero, P., González, F. A., Morado, M., Menor, M., de la Iglesia, S., López-Rubio, M., Salido, E. J., Abío, M., Senent, M. L., Recasens, V., Vagace, J. M., Fonte, C., Hernández-Rivas, J. M., Raya, J. M., Ríos, P., Peri, V. L., Herrera, K. A., Tenorio, M. C., …, & de Eritropatología, G. E. (2026). Beta‐Thalassemia in Spain: Results From the National Thalassemia Registry and Molecular Analysis of Patients With Transfusion‐Dependent Thalassemia. Journal of Clinical Laboratory Analysis, 40(14). https://doi.org/10.1002/jcla.70272

Vancouver

Villegas A, Ropero P, González FA, Morado M, Menor M, de la Iglesia S, et al. Beta‐Thalassemia in Spain: Results From the National Thalassemia Registry and Molecular Analysis of Patients With Transfusion‐Dependent Thalassemia. Journal of Clinical Laboratory Analysis. 2026;40(14). doi:10.1002/jcla.70272

BibTeX
@article{Villegas2026,
  author = {Villegas, Ana and Ropero, Paloma and González, Fernando Ataulfo and Morado, Marta and Menor, María and de la Iglesia, Silvia and López-Rubio, Montserrat and Salido, Eduardo José and Abío, Mariola and Senent, María Leonor and Recasens, Valle and Vagace, José Manuel and Fonte, Cristina and Hernández-Rivas, Jesús María and Raya, José María and Ríos, Pablo and Peri, Valeria Luciana and Herrera, Keneth A and Tenorio, María Concepción and Riso, Laura Lo and Tena, Juan and Molina, María Angustias and Vara, Miriam and Rodríguez, Isabel and Ricard, Pilar and Gómez, Miguel and Dusacovschi, Oana Popa and Vidán, Julia María and Groiss, Jorge and Ferre, Óscar and Orbe, Irene and López, Rosa María and Ugalde, Nazaret and Hidalgo, Manuela Inés and Hinojosa, Cristina and Rodríguez, Ana Isabel and Herrera, Esther and Murúzabal, María Josefa and Del Carmen Hernández, María and Marco, Josefa Esperanza and Benavente, Celina and de Eritropatología, Grupo Español},
  title = {Beta‐Thalassemia in Spain: Results From the National Thalassemia Registry and Molecular Analysis of Patients With Transfusion‐Dependent Thalassemia},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2026},
  volume = {40},
  number = {14},
  doi = {10.1002/jcla.70272}
}
Kostenlos starten →